课题基金 / 基金详情

CHARACTERIZATION OF INSULIN & INSULIN LIKE GROWTH FACTOR RESPONSES

CHARACTERIZATION OF INSULIN & INSULIN LIKE GROWTH FACTOR RESPONSES
胰岛素的特性
批准号：
6265406
负责人：
ALAN C MOSES
金额：
$2.98万
依托单位：
BETH ISRAEL DEACONESS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6265406
关键词：
clinical research drug screening /evaluation hormone regulation /control mechanism human subject human therapy evaluation insulin insulin sensitivity /resistance insulinlike growth factor

项目摘要

项目成果

ALAN C MOSES的其他基金

相关文献

中文摘要
翻译
1)确定各种严重胰岛素抵抗表型受试者的胰岛素抵抗程度和胰岛素分泌完整性。2)确定重度胰岛素抵抗受试者对胰岛素样生长因子I亚急性给药的反应。3)在表现出临床或生理反应的受试者中继续rhIGF-I治疗一年，作为确定长期安全性和疗效的方法。
英文摘要
1) To determine the degree of insulin resistance and integrity of insulin secretion in subjects with various phenotypes of severe insulin resistance. 2) To determine the response of subjects with severe insulin resistance to subactue administration of insulin-like growth factor I. 3) To continue rhIGF-I therapy for an additional year in subjects who demonstrate a clinical or physiologic response as a means of determining longer term safety and efficacy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INSULIN AND INSULINLIKE GROWTH FACTOR RESPONSES
INHALED HUMAN INSULIN VS USUAL SUBCUTANEOUS INSULIN THERAPY IN IDDM
PILOT STUDY OF A NOVEL, NONINVASIVE METHOD OF BLOOD GLUCOSE MONITORING
TROGLITAZONE IN MODERATE TO SEVERE INSULIN RESISTANCE